Similar articles

• Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.

  de Lemos ML, Monfared S, Denyssevych T, Hamata L, Jennings S, Thiessen B, Smith S, Waterhouse D. de Lemos ML, et al. J Oncol Pharm Pract. 2009 Mar;15(1):45-52. doi: 10.1177/1078155208096902. Epub 2008 Sep 4. J Oncol Pharm Pract. 2009. PMID: 18772215 Review.
• A simple technique to reduce preservative/excipient related neurotoxicity of intrathecal (spinal) drugs.

  Munir MA, Krishnan S, Ahmad M. Munir MA, et al. Anesth Analg. 2000 Mar;90(3):767-8. doi: 10.1097/00000539-200003000-00055. Anesth Analg. 2000. PMID: 10702476 No abstract available.
• Intrathecal chemotherapy-a word of caution.

  Siderov J. Siderov J. Ann Hematol. 2009 Oct;88(10):1039. doi: 10.1007/s00277-009-0715-9. Epub 2009 Mar 7. Ann Hematol. 2009. PMID: 19271218 No abstract available.
• Adverse reactions to the non-drug constituents of nebuliser solutions.

  Beasley R, Rafferty P, Holgate ST. Beasley R, et al. Br J Clin Pharmacol. 1988 Mar;25(3):283-7. doi: 10.1111/j.1365-2125.1988.tb03305.x. Br J Clin Pharmacol. 1988. PMID: 3358893 Free PMC article. No abstract available.
• Intrathecal methotrexate-induced neurotoxicities.

  Nelson RW, Frank JT. Nelson RW, et al. Am J Hosp Pharm. 1981 Jan;38(1):65-8. Am J Hosp Pharm. 1981. PMID: 7011005 Review.